Anurag Maheshwari, M.D., specializes in liver disease at The Center for Liver and Hepatobiliary Diseases, part of The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy in Baltimore, Maryland. His expertise helps patients seeking focused care for medical conditions of the liver.
Dr. Anurag Maheshwari provides experience in treating a range of concerns involving the liver including hepatitis, liver cancer, cirrhosis and bile duct conditions.
Dr. Maheshwari cares for patients in need of liver transplants and assists in pre- and post-operative transplant medical care, providing each patient individualized attention, coordination with liver transplant centers, and understanding as they progress toward recovery. Working with international authority Dr. Paul Thuluvath, Dr. Anurag Maheshwari is one of the physicians of The Institute for Digestive Health & Liver Disease at Mercy leading the way in the diagnosis and treatment of liver diseases.
Dr. Anurag Maheshwari works collaboratively with the specialists of The Institute for Cancer Care at Mercy, The Center for Minimally Invasive Surgery at Mercy, The Center for Interventional Pain Medicine at Mercy, The Lung Center at Mercy, and the Division of Interventional Radiology. This comprehensive approach to diagnosis and treatment of digestive tract diseases and the expertise of our doctors makes The Institute for Digestive Health & Liver Disease at Mercy one of the best in Baltimore and the Mid-Atlantic region.
Dr. Maheshwari has been named a "Top Doctor" in Gastroenterology/Liver Disease by Baltimore magazine.
Dr. Anurag Maheshwari is active in advanced research projects in liver diseases. He has authored many peer-reviewed publications and book chapters on issues in liver disease. Dr. Anurag Maheshwari is an active speaker and has appeared at conferences and hospital grand rounds around the country. He has been published in:
American Journal of Gastroenterology
Digestive Diseases and Sciences
Shakelford’s Surgery of the Alimentary Tract
Chair of the Department of Clinical Prevention, Roswell Park Cancer Institute
Areas of expertise: Family medicine, primary care, preventive medicine, health behavior, lung cancer, smoking cessation, HPV, vaccination
“You can learn to manage stress. You can develop a set of tools for bringing the level down. That can’t happen overnight though. You have to practice.”,“People with vulnerability towards depression and anxiety frequently experience the onset of such disorders around age 18.” ,“Loneliness, loss, sadness, these are all emotions that can impact a parent at this stage in life. Try to view it as good preparation for another major life stage that you’ll be confronting not too soon after this—retirement.","It can be difficult to show understanding when you strongly disagree with a friend's view, especially if it upsets your sense of right and wrong. But asking questions about why they feel that way -- rather than attacking -- is worth the effort."
Physician-scientist Dr. David Maloney is at the forefront of clinical trials to develop cell therapies for blood and other cancers, including understanding side effects of CAR T’s and how to deliver them in outpatient settings. A renowned researcher and clinician focusing on cancer immunotherapies and CAR T-cell therapies, he recently presented findings from the TRANSCEND trial for CD19 CAR T. This study showed that patients had improved quality-of-life (reduced fatigue and pain symptoms) starting six months after receiving CAR T-cell therapy.
Dr. Maloney focuses on using genetically engineered T cells (such as CAR-T) to treat patients with leukemia, lymphoma, myeloma and selected other cancers without causing graft vs. host disease that has been associated with transplantation. He was instrumental in developing and testing rituximab, the first antibody-based cancer drug on the market – one that has transformed the treatment of certain leukemias and lymphomas.
He is also an expert on blood-forming (hematopoietic) stem cell transplantation (HCT) in using a matched donor’s (allogeneic) or a patient’s own (autologous) stem cells in treatments for patients with hematologic malignancies. Recognizing that standard pre-transplant regimens are too toxic for many patients, Dr. Maloney and Fred Hutch colleagues are evaluating approaches that use antibodies to deliver radioactivity or cancer-killing drugs directly to tumors. They have also developed a less toxic, “reduced intensity” (nonmyeloablative) regimen that can more safely provide long-term remissions for patients with chronic lymphocytic leukemia (CLL), non-Hodgkin Lymphoma (NHL) and myeloma after allogeneic HCT.
Autologous HCT followed by reduced intensity allogenic HCT (tandem HCT) has proven effective for refractory NHL and myeloma patients. Dr. Maloney and colleagues have learned that nearly all of the anti-tumor activity of allogeneic HCT comes from the specific graft-vs-tumor activities of donor immune T cells, showing that antitumor immunity can be curative. Unfortunately, these T cells can also cause dangerous “graft-vs-host” effects on normal tissues.
Dr. Maloney continues exploring the use of antibodies as anti-cancer therapies, including newer anti-CD20 antibodies (e.g. ofatumumab, Arzerra®) for NHL patients, as well as radiolabeled antibodies, drug-carrying antibodies and unlabeled antibodies as targeted pre-transplant “conditioning” or as “maintenance” to extend remissions after allogeneic transplantation.
As medical director of the Cellular Immunotherapy Integrated Research Center at Fred Hutch, Dr. Maloney cares for patients at the Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance, the Hutch’s clinical-care partner. He is also professor of medicine in the Division of Oncology at the University of Washington.
“The current CAR T-cell therapies need to become more effective, more affordable and safer. We need to understand why they do not work for certain people, why they only work in select types of cancer and why they can cause severe, occasionally fatal, side effects.”,“It shows the unbelievable power of your immune system."
“Although narrow in scope, today’s FDA ruling is a milestone,” said Dr. David Maloney of the Fred Hutchinson Cancer Research Center in Seattle, whose team has worked with Juno and is researching CAR-T in a variety of cancers. “Approvals are an important s, “It represents a paradigm shift in treating cancers,” said Maloney, who is extensively involved in CAR T-cell research but not in the Novartis product.,“In general, aggressive cases of leukemia or in patients who are having symptoms, chemotherapy or some of the more targeted therapies are used.”
Dr. Markovic has developed a robust career in criminal justice, focusing on terrorism particularly focusing on suicide bombings, financing terrorism, and low-tech terrorist attacks such as vehicle-ramming attacks and mass shootings. Upon obtaining her doctoral degree, she became the Director of the Institute for the Study of Violent Groups (ISVG) at Sam Houston State University in Texas where she also served as Principal Investigator on a number of grants. She began her professional career in academia as an assistant professor at the University of New Haven, and eventually became Assistant Dean for the College of Criminal Justice. She has written widely on the topics of suicide terrorism including an op-ed for Forbes Magazine, and a recent publication (2019) in the journal on Women and Criminal Justice Terrorism special issue called “Suicide Squad: Boko Haram’s use of the female suicide bomber.” She is also a regular lecturer for the NATO Center of Excellence – Defense against Terrorism (COE-DAT) in Ankara, Turkey. She previously worked as a Private Investigator doing corporate due diligence Investigations at Search International.
Dr. Markovic’s research interests include terrorism, transnational crime, and comparative criminal justice.
Damion A. Martins, MD, is board-certified in sports medicine and internal medicine, and currently holds positions as the Medical Director of Sports Medicine, Director of the Executive Health and Program Director of the Sports Medicine Fellowship at Atlantic Health System.
Dr. Martins is an accomplished national leader in Sports Medicine with a proven track record in hospital administration. He not only treats thousands of professional and collegiate athletes, but develops the programs that enhance their performance. Dr Martins successfully oversaw a complex Orthopedic service line, consisting of 200+ physicians, covering five hospitals where he doubled both volume and revenue while increasing access and patient satisfaction. He was instrumental in developing Atlantic Health System’s Sports Cardiology and Sports Performance programs as well as the first Accountable Care Organization (ACO) designated Sports Medicine Center of Excellence. These programs have earned national quality recognition as Top 50 Orthopedic programs by U.S. News & World Report, 5 Star by Healthgrades and top 5% nationally for overall Orthopedic services.
As a recognized leader in the area of sports performance and exercise testing, Dr. Martins lectures extensively in the field of sports medicine. He is consistently recognized as a “Top Doctor” by Castle Connolly and is renowned for his research in hydration, musculoskeletal injuries and concussions. He is currently involved in a number of active research studies. His expertise has lent itself to the development of cardiovascular training programs widely used in the fitness industry and corporate wellness. He has authored over fifty publications including book chapters on the pre-participation exam and medical conditions that limit sports participation.
Dr. Martins is the director of internal medicine and team physician for the National Football League’s (NFL) New York Jets where he has served as a medical consultant since 2002, and member of the NFL Team Physician Society. As a former National Hockey League (NHL) Team Physician and member of the NHL Advisory Committee, he was instrumental in the development of the current National Hockey League’s pre-participation guidelines. His extensive experience on both the professional and collegiate levels also includes administrative medical director for Major League Soccer (MLS) and medical coverage for the U.S. Open Golf Championship, U.S. Open Tennis Championships, New York Islanders, New York Dragons, Hofstra University, and the College of St. Elizabeth. He is currently a medical advisor for New Jersey Interscholastic Athletic Association and Parisi Speed School.
Dr. Martins has dual academic appointments at Mount Sinai School of Medicine as assistant clinical professor in the departments of both medicine and orthopedics. He developed and is currently the program director of the American College of Graduate Medical Education (ACGME) accredited Sports Medicine Fellowship at Atlantic Health.
Dr. Martins graduated from Georgetown University School of Medicine, where he also obtained his Master’s degree in Exercise Physiology and Biophysics. He completed residency training in internal medicine at Georgetown University Medical Center. He completed his fellowship in sports medicine at the University of Maryland, where he served as fellow team physician for the NFL’s Baltimore Ravens and University of Maryland’s Terrapins.
“Information is a powerful motivator. Wearable trackers can be instrumental to one’s journey to fitness, but it’s truly the information that they convey about a person’s progress that helps keep them on track in a rewarding direction.”
Mattson’s research interests include improving the conceptualization and assessment of satisfaction in relationships and exploring the causes and consequences of functional versus dysfunctional relationship communication, including social support and intimate partner violence, respectively. His present focus is on how the effects of genetic, neuroendocrinological and early environmental factors, moderate the role of partner social support in buffering the negative impact of stress on health.
Assistant Professor in the Department of Psychiatry & Behavioral Sciences - Medical Director, Child Psychiatry Consultation Service - Training Director of Child and Adolescent Psychiatry Fellowship Program
Dr. Mavrides is a child and adolescent psychiatry expert who has been practicing for over 15 years. She is an expert in managing traumatic events in children and coaching parents on how to help their children recover. Dr. Mavrides was interviewed by media outlets throughout the country when the Marjory Stoneman Douglas/Parkland shooting took place as she is a Parkland resident who is also a Stoneman Douglas alum.
She is the Director of Child and Adolescent Psychiatry Services at the University of Miami Health System.
“We know that kids especially over the summer now, there's not much else to do, but they don’t need to be on their screen and on the news media all day every day. So, just really putting some limits in place can be really helpful for kids, but adults have to place themselves and really put the limits on and not allow themselves to be bombarded by the negative stuff all day.”,“I think there shouldn’t be a blanket one size fits all for anyone psychiatry, but especially with children – those who are from underserved populations or people who don’t have the internet capabilities or whatever – it’s been very difficult to get them into a Zoom or even a Facetime situation.”
Teach your child how to seek help when a bully is bothering them and how to walk away from a bully. Practice what to say so they will be prepared. Work with them on how to be assertive, encouraging them to stay with friends, if possible. ,“After what they went through, we put changing the world on their shoulders,” said Nicole Cook, a mother of two daughters who were at the school during the shooting. ,
Timothy McBride is an influential health policy analyst and leading health economist shaping the national agenda in health insurance, health reform, rural health care, Medicare and Medicaid policy, health economics, and access to health care. McBride studies the effects of health reform at the state and national levels, the uninsured, diabetes policy, Medicare Advantage, and long-term entitlement reform. McBride has been active in testifying before Congress and consulting with policy constituents on health reform, health insurance issues and rural health policy. He is a member of the Rural Policy Research Institute Health Panel that provides expert advice on rural health issues to the U.S. Congress and other policymakers.
Janet McCabe is director of the Environmental Resilience Institute at Indiana University and a professor of practice at the IU McKinney School of Law.
From July 2013 to January 2017, McCabe was the acting assistant administrator for the Office of Air and Radiation (OAR) at the U.S. Environmental Protection Agency, and was nominated by President Barack Obama to be assistant administrator of that office. She joined EPA in November 2009, serving as the principal deputy to the assistant administrator of OAR.
Prior to joining EPA, McCabe was executive director of Improving Kids’ Environment, Inc., a children’s environmental health advocacy organization based in Indianapolis, Ind., and was an adjunct faculty member at the IU School of Medicine, Department of Public Health, and at the School of Public and Environmental Affairs. From 1993 to 2005, she held several leadership positions in the Indiana Department of Environmental Management’s Office of Air Quality and was the office’s assistant commissioner from 1998 to 2005.
Before coming to Indiana in 1993, McCabe served as assistant attorney general for environmental protection for the Commonwealth of Massachusetts and assistant secretary for Environmental Impact Review. McCabe grew up in Washington, DC and graduated from Harvard College in 1980 and Harvard Law School in 1983.
“I’ve never seen a letter like this before. It’s ironic that EPA is taking California to task for not solving the air quality problem when for decades the state has been moving forward with the most aggressive clear air rules and programs in the nation.”,"This is uncharted territory. "The one thing everybody knows is that it will lead to years of litigation which will only distract people from actually doing the work of protecting public health and the planet from climate change impacts.","Since the  Paris [climate] summit, things have not gone so well. The U.S. has reversed course. We had a lot of moral authority in Paris, and it's not there anymore, and this is hard."
Joseph McCleery, Ph.D. is an assistant professor in the Department of Psychology, and Executive Director of Academic Programs in the Kinney Center for Autism Education and Support, at Saint Joseph's University. His research is focused along three major themes. The first theme involves examining and elucidating the mechanisms of social processing and perception in infants, children, and adults with and without Autism Spectrum Disorder (ASD). The second theme concerns the examination of genetic impacts on brain functioning, through the study of the relationships of normal genetic variation and rare genetic syndromes (e.g., mutations, microdeletions) with brain and behavioral functioning. The third theme involves the evaluation and development of behavioral and cognitive-behavioral interventions for individuals with ASD.
Dr. McCleery has published his research and ideas in leading peer-reviewed journals in the fields of Clinical Psychology, Psychiatry, and Neuroscience and his research has been supported by a number of organizations.
McCune has written widely on issues relating to masculinity, particularly black masculinity, as well as queer studies, sexuality theory, critical race theory, performance studies and popular culture. His book, “Sexual Discretion: Black Masculinity and the Politics of Passing” (University of Chicago Press, 2014), examines the lives of African-American men who have sex with men while maintaining a heterosexual lifestyle in public.
Kellie A. McElhaney is a leading expert on equity fluent leadership, value-creating strategies of diversity and inclusion, and corporate social responsibility. She is on the Berkeley Haas faculty as a Distinguished Teaching Fellow and is the Founding Director of the Center for Equity, Gender and Leadership (EGAL).
Launched in November 2017, EGAL’s mission is to educate equity fluent leaders to ignite and accelerate change. Equity fluent leaders understand the value of different lived experiences and courageously use their power to address barriers, increase access, and drive change for positive impact. McElhaney helped develop the equity fluent leadership concept and teaches it across the country and around the world.
In 2003, McElhaney founded the Center for Responsible Business, solidifying corporate responsibility as a core competency and competitive advantage for the Haas School. Haas was rated #1 in the world for corporate responsibility by The Financial Times. She received the Founder and Visionary Award at Haas in 2013 for this work.
McElhaney wrote a book entitled “Just Good Business: The Strategic Guide to Aligning Corporate Responsibility and Brand.” She writes case studies of companies who are investing in women and equity-fluent leadership (Wal-Mart, Gap, Inc., Boston Consulting Group, Zendesk), and conducts research in the area of equal, pay, conscious inclusion, equity fluent leadership, and value-creating strategies of diversity and inclusion.
McElhaney consults and keynotes for Global 1000 companies and organizations all over the world on her areas of expertise, and has a TED talk.
“While the commitment to diversity and an inclusive work environment is there, too few have a handle on solutions".
When you hear that someone makes a list of top most influential leaders, it’s easy to assume they were driven by a clear vision for their career since they were young.,,There’s a strong business case to be made for promoting women’s involvement in the business world, let’s not forget; Harvard-Haas Business School’s Kellie McElhaney has made that case for years, using hard numbers to demonstrate that companies with a larg
McMichael has published numerous articles and book chapters on the subjects of scalp and hair disorders and quality of life issues surrounding disorders of pigmentation. She is listed in Best Doctors in America and is a diplomat of the American Board of Dermatology. McMichael has served on several editorial review boards and is a contributing editor for Cosmetic Dermatology as well as a contributing editor for reviews in The Dermatologist.
Laxmi Mehta, M.D., FACC, FAHA is the Director of the Women’s Cardiovascular Health Program and an Associate Professor of Medicine at The Ohio State University Wexner Medical Center. Dr. Mehta is also the Associate Program Director for Education for Ohio State’s Center for Women’s Health.
She is the President of the Ohio Chapter of the American College of Cardiology and has previously served two terms as Secretary/Treasurer for the Ohio-ACC Chapter. Additionally, she is the Immediate Past President of the metro Columbus Board of Directors for the American Heart Association and now currently serves on the Great Rivers Affiliate Board for the American Heart Association. She sits on several national committees for both the American College of Cardiology and the American Heart Association. Dr. Mehta was chosen by Business First Magazine as one of Columbus' Top 40 under 40 in 2010 and honored as one of 12 women for the 2012 Women for Economic Leadership (WELD) Women You Should Know Calendar Honoree.
She specializes in women’s cardiovascular health, prevention and cardiac imaging. Dr. Mehta is an avid promoter and educator on women’s cardiovascular health and has published a number of peer-reviewed articles and book chapters. She is a Fellow of the American College of Cardiology and the American Heart Association. She received her M.D. degree from Northeastern Ohio Universities Colleges of Medicine and Pharmacy in Rootstown, Ohio in 1998. She completed her Internal Medicine residency training and Clinical Cardiology fellowship training at William Beaumont Hospital in Royal Oak, Michigan in 2001 and 2005.
“Unfortunately, many women don’t make their own personal health their priority,” she says, “which contributes to more favorable outcomes in men versus women after a heart attack. From my experience, most men attend cardiac rehab, unless work issues preven,“Over the last 10 years or so, we’ve learned that women’s hearts are different than men’s in some significant ways, and while that’s helped reduce mortality, there’s much more to know,” said Mehta, who is also director of Ohio State’s Women's Cardiovascul
Dr. Mielcarek believes that individualizing treatment according to the patient's needs and philosophy, combined with incorporating up-to-date research knowledge, are key ingredients for excellent patient care.
Blood stem cell and bone marrow transplantation for hematologic malignancies
Graft-versus-Host Disease (GVHD)
Medical Director, Adult Blood and Marrow Transplant Program, Seattle Cancer Care Alliance
Member, Clinical Research Division, Fred Hutch
Professor of Medicine, Department of Medical Oncology, University of Washington
Education and Training
MD: Freie Universität Berlin, 1986
PhD: Freie Universität Berlin, 1987
Residency: Freie Universität Berlin, Internal Medicine, 1987-1993
Research Fellowship: Fred Hutchinson Cancer Research Center, 1994-1999
Residency: University of Washington, Internal Medicine, 1999-2000
Fellowship: University of Washington, Medical Oncology, 2000-2003
Randall M. Miller, Ph.D. is the William Dirk Warren `50 Sesquicentennial Chair and professor of history at Saint Joseph’s University. He is the author or editor of more than 25 books on subjects as varied as the American Revolution, the Civil War and Reconstruction, slavery and race, immigration and ethnicity, civil rights, regional identities (especially the Mid-Atlantic and the American South), and politics, to name several. He is currently working on a book on immigrants in the American South. Among his books are the acclaimed “Dear Master”: Letters of a Slave Family and (with Paul Cimbala) The Northern Home Front during the Civil War.
Dr. Miller also has been an “activist-historian,” arguing that history can be an instrument of social understanding and change. He was a principal advocate for a new interpretation of “freedom” and “unfreedom” at Independence National Historical Park, where his efforts helped to lead to a memorial commemorating the lives of the nine slaves who served at President George Washington’s house at Sixth and Market Streets in Philadelphia.
Natalie B. Milman, Ph.D. is Professor of Educational Technology and Director of the Educational Technology Leadership Program at The George Washington University and a member of the interdisciplinary Human-Technology Collaborations Ph.D. program and research lab (go.gwu.edu/htc). She is on the steering committee and a member of GW’s Academy of Distinguished Teachers and winner of the 2017 Bender Teaching Award. Her research focuses on the design of instruction and models for the effective leadership and integration of technology at all academic levels; online student support needs, engagement, and learning; issues of diversity, inclusion, and digital equity; and the use of digital portfolios for professional development.
She serves as the co-editor of the Current Practice Section of "Contemporary Issues in Technology and Teacher Education" and has published numerous journal articles, including in "Computers in the Schools," "Journal of Research on Technology and Education," "Journal of Technology and Teacher Education," "Online Learning," and the "Quarterly Review of Distance Education." She presents frequently at conferences and has co-authored several book chapters and books. Her most recent book is entitled, "Teaching Models: Designing Instruction for 21st Century Learners."
Dr. Milman earned a doctorate in Instructional Technology from the University of Virginia’s Curry School of Education with a graduate specialization designed to prepare technology leaders. She began her career in education as a second grade, science specialist, mentor, and technology teacher in Los Angeles County, California. She has taught at the graduate school level since 1997 and online since 2001.
“I believe students need to make a distinction between their perceptions and experiences of the residential college experience and a well-designed online class and you know, it’s hard to take those two apart because what many students have experienced is a residential college experience, but that’s not everyone’s experience.”,“This is hard. It’s hard on all of us. And for some extremely difficult – some of us have experienced a great deal of loss. If there's anything that I have seen really come to the fore – it’s that idea of caring and the need for social and emotional wellbeing.”
I have taught online for nearly 20 years. As an online professor at George Washington University, my courses continued through the 9/11 terrorist attacks, beltway snipers, Hurricane Isabel, the H1N1 virus, and "Snowmaggedon.,An article written by Natalie B. Milman in Education Week, a news journal focusing on K-12 education, on March 30, the day the city’s first coronavirus death hit the news, described what was going on in the nation’s schools as “emergency remote teaching.”
Jodi A. Mindell, Ph.D., is a Professor of Psychology and Director of Graduate Psychology at Saint Joseph's University. She is a clinical psychologist specializing in pediatric sleep medicine. Dr. Mindell has written extensively on pediatric sleep disorders and presented over 350 papers at national and international conferences. Her research focuses on assessment and treatment of infant and toddler sleep disturbances, cross-cultural differences in sleep in young children, and the impact of sleep on development. She is the chair of the Pediatric Sleep Council (BabySleep.com) and author of Sleeping Through the Night: How Infants, Toddlers, and Their Parents Can Get a Good Night's Sleep (HarperCollins).